Acute lymphoblastic leukaemia (n = 22) | Other malignancy (n = 26) | Boys (n = 23) | Girls (n = 25) | |
---|---|---|---|---|
Mean (SD) absolute BMD | ||||
Lumbar BMD (g/cm2) | 0.72 (0.19) (n = 22) | 0.79 (0.22) (n = 25) | 0.77 (0.22) (n = 22) | 0.74 (0.20) (n = 25) |
Lumbar BMDvol (g/cm3) | 0.27 (0.041) (n = 22) | 0.30 (0.044) (n = 25) | 0.28 ( 0.041) (n = 22) | 0.29 (0.047) (n = 25) |
Femoral BMD (g/cm2) | 0.77 (0.14) (n = 12) | 0.83 (0.13) (n = 16) | 0.83 ( 0.14) (n = 14) | 0.78 (0.13) (n = 14) |
Femoral BMDvol (g/cm3) | 0.35 (0.041) (n = 12) | 0.36 (0.050) (n = 16) | 0.35 ( 0.051) (n = 14) | 0.36 (0.041) (n = 14) |
Mean Z scores (95% CI) | ||||
Lumbar BMD | −0.36 (−0.99 to 0.27) | −0.08 (−0.62 to 0.46) | 0.13 (−0.62 to 0.89) | −0.52 (−0.88 to −0.15)3-150 |
Lumbar BMDvol | −0.77 (−1.30 to −0.23)3-150 | −0.04 (−0.58 to 0.49) | −0.21 (−0.92 to 0.51) | −0.54 (−0.92 to −0.16)3-150 |
Femoral BMD | −1.02 (−1.52 to −0.53)3-150 | −0.70 (−1.19 to −0.21)† | −0.89 (−1.48 to −0.30)3-150 | −0.79 (−1.21 to −0.37)3-150 |
Femoral BMDvol | −0.98 (−1.64 to −0.32)3-150 | −0.78 (−1.38 to −0.19)3-150 | −0.91 (−1.62 to −0.21)3-150 | −0.83 (−1.36 to −0.29)3-150 |
↵3-150 p ⩽ 0.01; †p = 0.02; both compared with controls.